时间标签：数据日期 2026-11-01 · 生成时间 2026-11-01 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/10/31–2026/11/01 ｜ 情报发生日期 2026-11-01
证据级别：摘要级。本条依据 PubMed 结构化摘要与元数据撰写，付费墙全文未获取、未逐节核验，本站未做任何数值推算补全。
研究问题
This study aimed to determine sarcopenia status in patients with Parkinson's disease (PD), classified as early-stage (<2.5) and moderate-stage (≥2.5) by the Modified Hoehn and Yahr Scale, and in healthy controls using the ICF-based…
方法
A total of 63 participants were included in this cross-sectional study: 42 patients with PD and 21 healthy controls.；Participants were classified as non-sarcopenic, dynapenic, or sarcopenic according to ISarcoPRM criteria.
核心结论
The prevalence of sarcopenia differed significantly across groups (P=0.016), with higher rates observed in patients with moderate-stage PD.
局限
A total of 63 participants were included in this cross-sectional study: 42 patients with PD and 21 healthy controls.
对本项目的价值
观察性关联，仅用于假说生成，不可作因果：功能结局（衰弱 / 肌少症）是临床转化最可及的终点，适合作为一期终点候选。 ｜ 价值分 1.0/5（★☆☆☆☆）
全文来源
未取到全文 → 本卡为摘要级解读，未核验全文
原文题录
- 英文标题：Stage-Dependent Sarcopenia Status in Parkinson's Disease: An ICF-Based ISarcoPRM Algorithm.
- 期刊与标识：American journal of physical medicine & rehabilitation · PMID 42952010 · DOI 10.1097/phm.0000000000003188
A 级证据分级：A 级（同行评议人体研究）
本文属人体研究证据，但需注意：观察性或小样本干预的结论不等于已证实临床获益；效应量与长期安全性仍需更大规模、更长随访的试验验证。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」（SOP §4.2 摘要级）撰写，依据期刊公开摘要与 PubMed 元数据；付费墙全文未获取之处已标注「待补全文」，未做任何数值推算补全。